What Do Pharmaceutical Companies Owe to Patients? Examining the (Un)ethical Aspects of the Pharmaceutical Industry's Practices

Turkish Journal of Bioethics
doi 10.5505/tjob.2015.03511
Full Text
Abstract

Available in full text

Date
Authors
Publisher

LookUs Bilisim A.S.

Related search

Small Pharmaceutical Companies

Organic Process Research and Development
Organic ChemistryTheoretical ChemistryPhysical
2004English

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2011English

Profitability of Pharmaceutical Companies in the Visegrád Countries

Montenegrin Journal of Economics
EconomicsEconometricsFinance
2019English

Pharmaceutical Aspects of Silver Nanoparticles

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2017English

International Best Practices for Negotiating 'Reimbursement Contracts' With Price Rebates From Pharmaceutical Companies

Health Affairs
MedicineHealth Policy
2013English

Success of Ophthalmic Pharmaceutical Start-Up Companies

Acta Ophthalmologica
MedicineOphthalmology
2017English

New Ethical Framework for Pharmaceutical Physicians

BMJ
2006English

Good Publication Practice for Pharmaceutical Companies

Current Medical Research and Opinion
Medicine
2003English

Aspects Regarding the Pharmaceutical Waste Management in Romania

Sustainability
DevelopmentManagementMonitoringEnvironmental ScienceRenewable EnergyEnergy EngineeringLawSustainabilityPlanningPolicyPower Technologythe EnvironmentGeography
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy